Liver Resection as a Bridge to Transplantation for Hepatocellular Carcinoma on Cirrhosis

Adam, René; Azoulay, Daniel; Castaing, Denis; Eshkenazy, Rony; Pascal, G.; Hashizume, Kenji; Samuel, Didier; Bismuth, H

doi:10.1097/01.sla.0000090449.87109.44

Cited by 331 publications

(229 citation statements)

References 49 publications

Supporting

Mentioning

208

Contrasting

Unclassified

Order By: Relevance

“…For potential recipients with recurrent hepatocellular carcinoma and a poor liver function, the chance of a curative liver transplantation ought to be estimated. 37 This has to be interpreted with current opinions 37,38 and local results. 39 Continuity of care by the same team of surgeons is logical.…”

Section: Discussionmentioning

confidence: 99%

Donor quality of life before and after adult-to-adult right liver live donor liver transplantation

Chan

Liu

et al. 2006

Liver Transpl

View full text Add to dashboard Cite

Donor right hepatectomy for adult-to-adult live donor liver transplantation (ALDLT) is a major surgical operation for the benefit of the recipient. Justification of procedure mandates knowledge of the possible physical and psychological negative effects on the donor. We prospectively and longitudinally quantified donor quality of life using generic and condition-specific questionnaires up to 1 year. The generic questionnaires were the Karnofsky Performance Status scale and the Chinese (Hong Kong) version of the Medical Outcomes Study 36-Item Short-Form Survey, which measures 8 health concepts: 4 physical components and 4 mental components. Within 1 year, 30 consecutive donors were included. These 11 male and 19 female donors (36.7% and 63.3%, respectively) had a median age of 35 years (range, 21-56 years). There was no donor mortality or major complications. Donor quality-of-life worsening was most significant in the first 3 postoperative months, particularly among the physical components. The physical and mental components returned to the previous levels in 6 to 12 months' time, though the Karnofsky performance scores were slightly lower at 1 year (P ϭ 0.011). Twenty-six (86.7%) donors declared that they would donate again if there were such a need and it were technically possible. It was noticed that older donors were more likely to express unwillingness to donate again. In conclusion, the temporary worsening of donor quality of life substantiates ALDLT as an acceptable treatment modality. Liver Transpl 12: 1529-1536, 2006.

show abstract

Section: Discussionmentioning

confidence: 99%

Donor quality of life before and after adult-to-adult right liver live donor liver transplantation

Chan

Liu

et al. 2006

Liver Transpl

View full text Add to dashboard Cite

show abstract

“…200 Published series from the past two decades tend to provide perioperative mortality rates of under 15%, with the most recent predominantly falling in the range 2-8%. 193,194,199,[201][202][203][204][205][206][207][208][209][210][211][212][213] One UK unit has reported that, during their experience with OLT for small HCC from 1995 to 1999, there were four perioperative mortalities in 30 cases (13.3%).…”

Section: Perioperative Mortalitymentioning

confidence: 99%

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis

Coon¹,

Rogers²,

Hewson³

et al. 2007

Health Technol Assess

151

108

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. Declared competing interests of authors: K Stein received an unrestricted grant from Schering Plough (UK) to carry out work on the cost-effectiveness of combination therapy for hepatitis C in 2000. KS is also a member of the editorial board for Health Technology Assessment, but he was not involved in the editorial process for this report. M Cramp sits on hepatitis C advisory boards for Schering Plough, Gilead and Roche. He has received unrestricted educational grants from Roche and Schering Plough to support research and service development. He has been awarded an NHS R&D grant looking at injecting drug users who do not have hepatitis C virus infection. J Thompson Coon received a grant from the Hepatitis C Trust to conduct a systematic review of complementary and alternative therapies for the treatment of chronic hepatitis C. HTA Published September 2007This report should be referenced as follows: NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) programme, now part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the costs, effectiveness and broader impact of health technologies for those who use, man...

show abstract

“…A study based on analysis of the European Liver Transplant Registry indicated that HCC recurrence in patients who previously underwent liver resection would often present with multiple tumor nodules, and only 25% of patients with recurrent tumors fulfilled the Milan criteria (Mergental and Porte, 2010). Studies also indicated that liver transplant was only feasible in 23% of patients with recurrent HCC (Adam et al, 2003). Our clinical data show that in patients with recurrent HCC beyond the Milan criteria, the 3-year recurrence rate and overall survival rate after SLT are 86.1%, and 40.6%, respectively .…”

Section: Recurrent Hepatocellular Carcinomamentioning

confidence: 99%

Surgical treatment of hepato-pancreato-biliary disease in China: the Tongji experience

Zhang

Wang

Luo

et al. 2016

Sci. China Life Sci.

View full text Add to dashboard Cite

Hepato-pancreato-biliary (HPB) tumors are common in China. However, these tumors are often diagnosed at intermediate/advanced stages because of the lack of a systemic surveillance program in China. This situation creates many technical challenges for surgeons and increases the incidence of postoperative complications. Therefore, Dr. Xiao-Ping Chen has made many important technical improvements, such as Chen's hepatic portal occlusion method, the anterior approach for liver resection of large HCC tumors, the modified technique of Belghiti's liver-hanging maneuver, inserting biliary-enteric anastomosis technique, and invaginated pancreaticojujunostomy with transpancreatic U-sutures. These techniques are simple, practical, and easy to learn. Owing to these advantages, complicated surgical procedures can be simplified, and the curative effects are greatly improved. These improved techniques have been widely applied in China and will benefit many additional patients. In this review, we introduce our experience of surgically treating intermediate/advanced hepatocellular carcinoma (HCC), hilar cholangiocarcinoma (HC), and pancreatic carcinoma, mainly focusing on technical innovations established by Dr. Chen in HPB surgery. hepatocellular carcinoma, liver transplantation, hilar cholangiocarcinoma, pancreaticojejunostomy

show abstract

Liver Resection as a Bridge to Transplantation for Hepatocellular Carcinoma on Cirrhosis

Cited by 331 publications

References 49 publications

Donor quality of life before and after adult-to-adult right liver live donor liver transplantation

Donor quality of life before and after adult-to-adult right liver live donor liver transplantation

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis

Surgical treatment of hepato-pancreato-biliary disease in China: the Tongji experience

Contact Info

Product

Resources

About